Lymphadenopathy epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Lymphadenopathy}} | {{Lymphadenopathy}} | ||
{{CMG}}; {{AE}} {{RT}} | {{CMG}}; {{AE}} {{RT}} | ||
==Overview== | ==Overview== | ||
The estimated incidence of [[lymphadenopathy]] in children in the United States ranges from 35% - 45%. It is more common in the pediatric population. Race and gender have no predilection in lymphadenopathy incidence. | |||
The estimated incidence of [[lymphadenopathy]] in children in the United States ranges from 35% - 45%. | |||
It is more common in the pediatric population. | |||
Race and gender have no predilection in lymphadenopathy incidence. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:primary care]] | |||
[[Category:Inflammations]] | |||
[[Category:Dermatology]] | |||
[[Category:Signs and symptoms]] | |||
[[Category:Infectious disease]] | |||
[[Category:Hematology]] | |||
[[Category:Oncology]] | |||
[[Category:Physical examination]] | |||
[[Category:Needs content]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 16:25, 8 March 2013
|
Lymphadenopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lymphadenopathy epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Lymphadenopathy epidemiology and demographics |
|
Risk calculators and risk factors for Lymphadenopathy epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]
Overview
The estimated incidence of lymphadenopathy in children in the United States ranges from 35% - 45%. It is more common in the pediatric population. Race and gender have no predilection in lymphadenopathy incidence.